Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Day One Biopharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 922 shares
@ $13.86, valued at
$12.8k
Exercised 1,375 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Disposed of 240,288 shares
@ $0
Acquired 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 240,288 shares
@ $0
Gifted 59,737 shares
@ $0
Gifted 59,737 shares
@ $0
Gifted 29,938 shares
@ $0
Gifted 29,938 shares
@ $0 |
|
| 06/12/2023 |
4
| AI Day1 LLC (10% Owner) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Bought 769,230 shares
@ $13, valued at
$10M
|
|
| 06/07/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,229 shares
@ $16, valued at
$19.7k
|
|
| 05/17/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 955 shares
@ $13.1223, valued at
$12.5k
Exercised 1,375 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 692 shares
@ $13.1223, valued at
$9.1k
Exercised 1,187 restricted stock units
@ $0
Exercised 1,437 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 3,104 shares
@ $13.1223, valued at
$40.7k
Exercised 3,562 restricted stock units
@ $0
Exercised 4,750 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $18.0484, valued at
$180.5k
|
|
| 03/08/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0091, valued at
$250.1k
|
|
| 02/21/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 9,377 shares
@ $20.0267, valued at
$187.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $21.999, valued at
$275k
|
|
| 01/23/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $22.7523, valued at
$227.5k
|
|
| 01/19/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 116,000 options to buy
@ $20.87, valued at
$2.4M
Granted 36,000 restricted stock units
@ $0 |
|
| 01/19/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 72,000 options to buy
@ $20.87, valued at
$1.5M
Granted 23,000 restricted stock units
@ $0 |
|
| 01/19/2023 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 244,000 options to buy
@ $20.87, valued at
$5.1M
Granted 76,000 restricted stock units
@ $0 |
|
| 01/11/2023 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 7,500 shares
@ $22.751, valued at
$170.6k
Sold 2,500 shares
@ $23.2045, valued at
$58k
|
|
| 01/04/2023 |
4
| Grant Julie Papanek (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 17,390 shares
@ $20.355, valued at
$354k
Sold 7,610 shares
@ $21.3106, valued at
$162.2k
|
|
| 12/14/2022 |
4
| Atlas Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Disposed of 600,854 shares
@ $0 |
|
| 12/12/2022 |
4
| Grant Julie Papanek (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 4,358 shares
@ $22.0767, valued at
$96.2k
|
|
| 12/05/2022 |
4
| Grant Julie Papanek (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 4,760 shares
@ $21.7213, valued at
$103.4k
Sold 240 shares
@ $22.3375, valued at
$5.4k
Sold 5,000 shares
@ $21.5452, valued at
$107.7k
|
|
| 12/05/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 9,100 shares
@ $21.3835, valued at
$194.6k
Sold 900 shares
@ $22.1556, valued at
$19.9k
|
|
| 11/22/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 9,700 shares
@ $20.7374, valued at
$201.2k
Sold 300 shares
@ $21.39, valued at
$6.4k
|
|
| 11/22/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,100 shares
@ $20.7378, valued at
$250.9k
Sold 400 shares
@ $21.38, valued at
$8.6k
|
|
| 11/17/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 430 shares
@ $21.4598, valued at
$9.2k
Exercised 1,375 restricted stock units
@ $0 |
|
| 11/17/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 377 shares
@ $21.4598, valued at
$8.1k
Exercised 1,187 restricted stock units
@ $0 |
|
| 11/17/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,513 shares
@ $21.4598, valued at
$32.5k
Exercised 3,562 restricted stock units
@ $0 |
|
| 11/03/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $20.0313, valued at
$200.3k
|
|
| 11/03/2022 |
4
| Grant Julie Papanek (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $20.0417, valued at
$100.2k
Sold 5,000 shares
@ $20.0138, valued at
$100.1k
|
|
| 11/03/2022 |
4
| Blackman Samuel C. (Chief Medical Officer) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $20.005, valued at
$200.1k
|
|
| 11/03/2022 |
4
| Bender Jeremy (CEO) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 12,500 shares
@ $20.0284, valued at
$250.4k
|
|
|
|
|